C92.A1

HCC Category Mapping

What This Code Means

A type of acute myeloid leukemia where multiple cell lines show abnormal development and the cancer has responded to treatment and is in remission.

Coding Tips

• •Document the multilineage dysplasia findings from the pathology report
• •Ensure remission status is explicitly documented in the medical record

Clinical Significance

Acute myeloid leukemia with multilineage dysplasia in remission indicates successful treatment response in this typically adverse-prognosis AML subtype. Achieving remission in AML-MLD may require more intensive induction regimens, and many patients are considered for allogeneic stem cell transplantation in first remission given the high relapse risk. The dysplastic features reflect underlying stem cell abnormalities that persist even in morphologic remission.

Documentation Requirements

• ✓Documentation must confirm the AML-MLD diagnosis and explicit remission status with bone marrow showing less than 5% blasts and count recovery.
• ✓Note whether dysplastic features persist in remission bone marrow, as this may indicate residual MDS clone.
• ✓MRD assessment, transplant candidacy evaluation, and post-remission therapy plan must be documented.
• ✓The cytogenetic and molecular risk profile should guide consolidation strategy.

Commonly Confused Codes